Global Biopharmaceutical Equipment Market

Biopharmaceutical Equipment Comprehensive Study by Type (Filtration Systems, Bioreactors, Extractors, Chromatography, Cell Culture, Bioprocessing Containers, Sterilizers, Others), Application (Bioproduction, Medical Research), End Use (Pharmaceuticals, Supplements, Fertilizers, Others) Players and Region - Global Market Outlook to 2027

Biopharmaceutical Equipment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Biopharmaceutical Equipment Market Scope
Biopharmaceuticals, also known as bio-pharma, are the intersection of biotechnology and pharmaceutical production. The use of living organisms or extractions, by-products, or elements of living organisms to prevent, relieve, or treat diseases is known as bio-pharma. The process by which drugs are developed is the primary distinction between biopharmaceuticals and conventional pharmaceuticals. Over the last few decades, the biopharmaceutical industry (which includes small molecule medications, biologics, and vaccines) and the medical equipment industry (which includes implantable medical instruments, diagnostic imaging, and other diagnostics) have been significant contributors to both increasing healthcare expenditure and increased quality and quantity of life. As the therapeutic significance and economic value of biological products become better known, new problems arise due to the various technical shortcomings involved with the production and distribution of these complex agents, thereby deriving demand for Biopharmaceutical Equipment.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Biopharmaceutical Equipment market throughout the predicted period.

3M Company (United States), Merck Group (Germany), GE Healthcare (United States), Danaher Corporation (United States), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (United States), Agilent Technologies, Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Eppendorf AG (Germany) and Repligen Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Philips Healthcare (Netherlands), Abbott Laboratories (United States), Roche Holding AG (Switzerland) and Sodexo (France).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Biopharmaceutical Equipment market by Type (Filtration Systems, Bioreactors, Extractors, Chromatography, Cell Culture, Bioprocessing Containers, Sterilizers and Others), by Application (Bioproduction and Medical Research) and Region with country level break-up.

On the basis of geography, the market of Biopharmaceutical Equipment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 7th September, 2018 - Thermo Fisher Acquired BD’s (Becton, Dickinson and Company) Advanced Bioprocessing Business, This Acquisition Will Add Cell Culture Media Formulations Will Improve Thermo Fisher’s Existing Biomanufacturing Capabilities. and On 6th January, 2021 - Sartorius Stedim Biotech Announced Its Plans to Acquire Novasep's Chromatography Process Equipment Division Which Consists of Resin-Based Batch and Amplified Chromatography Systems, With an Emphasis on High-Pressure, Multi-Use Applications for Smaller Molecules Including Oligonucleotides, Insulin, And Peptides.
On 5th December, 2020 – Sodexo (French Biopharma Equipment Manufacturer) Launched First Bio-Medical Equipment Mobile Application for the Indian Region. Under the App Small to Medium Hospital Clinics, Diagnostic Centers, And Laboratories Can Avail Immediate Access to Quality Medical Equipment Repair Programs.
United States, FDA “Current Good Manufacturing Practice (CGMP) Regulations” – Provides Framework to Ensure Goods Are Continuously Manufactured and Regulated in Compliance with Quality Requirements. It's Intended to Reduce Any Dangers Associated with Pharmaceutical Manufacturing. Any New Entrant or Producer is Required to have a Regulatory Approval from FDA Regarding the Sale and Manufacturing of the Equipment Across the US.

Market Trend
  • Technical Progress in Medical Industry
  • Heavy Investments in Research & Development

Market Drivers
  • Emergence of Advance and Effective Techniques
  • Surge in Demand for Bio Products

Opportunities
  • Growth in Healthcare infrastructure Due to Pandemic
  • Low Penetration in Emerging Region Particularly Asia

Restraints
  • Highly Priced Surgical Equipment

Challenges
  • Fierce Competitive Pressure


Key Target Audience
Biopharmaceutical Equipment Manufactures, New Entrants and Investors, Biopharmaceutical Equipment Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Filtration Systems
  • Bioreactors
  • Extractors
  • Chromatography
  • Cell Culture
  • Bioprocessing Containers
  • Sterilizers
  • Others
By Application
  • Bioproduction
  • Medical Research
By End Use
  • Pharmaceuticals
  • Supplements
  • Fertilizers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Emergence of Advance and Effective Techniques
      • 3.2.2. Surge in Demand for Bio Products
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry
      • 3.4.2. Heavy Investments in Research & Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biopharmaceutical Equipment, by Type, Application, End Use and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biopharmaceutical Equipment (Value)
      • 5.2.1. Global Biopharmaceutical Equipment by: Type (Value)
        • 5.2.1.1. Filtration Systems
        • 5.2.1.2. Bioreactors
        • 5.2.1.3. Extractors
        • 5.2.1.4. Chromatography
        • 5.2.1.5. Cell Culture
        • 5.2.1.6. Bioprocessing Containers
        • 5.2.1.7. Sterilizers
        • 5.2.1.8. Others
      • 5.2.2. Global Biopharmaceutical Equipment by: Application (Value)
        • 5.2.2.1. Bioproduction
        • 5.2.2.2. Medical Research
      • 5.2.3. Global Biopharmaceutical Equipment by: End Use (Value)
        • 5.2.3.1. Pharmaceuticals
        • 5.2.3.2. Supplements
        • 5.2.3.3. Fertilizers
        • 5.2.3.4. Others
      • 5.2.4. Global Biopharmaceutical Equipment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biopharmaceutical Equipment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Group (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sartorius AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thermo Fisher Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Agilent Technologies, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eppendorf AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Repligen Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biopharmaceutical Equipment Sale, by Type, Application, End Use and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biopharmaceutical Equipment (Value)
      • 7.2.1. Global Biopharmaceutical Equipment by: Type (Value)
        • 7.2.1.1. Filtration Systems
        • 7.2.1.2. Bioreactors
        • 7.2.1.3. Extractors
        • 7.2.1.4. Chromatography
        • 7.2.1.5. Cell Culture
        • 7.2.1.6. Bioprocessing Containers
        • 7.2.1.7. Sterilizers
        • 7.2.1.8. Others
      • 7.2.2. Global Biopharmaceutical Equipment by: Application (Value)
        • 7.2.2.1. Bioproduction
        • 7.2.2.2. Medical Research
      • 7.2.3. Global Biopharmaceutical Equipment by: End Use (Value)
        • 7.2.3.1. Pharmaceuticals
        • 7.2.3.2. Supplements
        • 7.2.3.3. Fertilizers
        • 7.2.3.4. Others
      • 7.2.4. Global Biopharmaceutical Equipment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biopharmaceutical Equipment: by Type(USD Million)
  • Table 2. Biopharmaceutical Equipment Filtration Systems , by Region USD Million (2016-2021)
  • Table 3. Biopharmaceutical Equipment Bioreactors , by Region USD Million (2016-2021)
  • Table 4. Biopharmaceutical Equipment Extractors , by Region USD Million (2016-2021)
  • Table 5. Biopharmaceutical Equipment Chromatography , by Region USD Million (2016-2021)
  • Table 6. Biopharmaceutical Equipment Cell Culture , by Region USD Million (2016-2021)
  • Table 7. Biopharmaceutical Equipment Bioprocessing Containers , by Region USD Million (2016-2021)
  • Table 8. Biopharmaceutical Equipment Sterilizers , by Region USD Million (2016-2021)
  • Table 9. Biopharmaceutical Equipment Others , by Region USD Million (2016-2021)
  • Table 10. Biopharmaceutical Equipment: by Application(USD Million)
  • Table 11. Biopharmaceutical Equipment Bioproduction , by Region USD Million (2016-2021)
  • Table 12. Biopharmaceutical Equipment Medical Research , by Region USD Million (2016-2021)
  • Table 13. Biopharmaceutical Equipment: by End Use(USD Million)
  • Table 14. Biopharmaceutical Equipment Pharmaceuticals , by Region USD Million (2016-2021)
  • Table 15. Biopharmaceutical Equipment Supplements , by Region USD Million (2016-2021)
  • Table 16. Biopharmaceutical Equipment Fertilizers , by Region USD Million (2016-2021)
  • Table 17. Biopharmaceutical Equipment Others , by Region USD Million (2016-2021)
  • Table 18. South America Biopharmaceutical Equipment, by Country USD Million (2016-2021)
  • Table 19. South America Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 20. South America Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 21. South America Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 22. Brazil Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 23. Brazil Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 24. Brazil Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 25. Argentina Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 26. Argentina Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 27. Argentina Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 28. Rest of South America Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 29. Rest of South America Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 30. Rest of South America Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 31. Asia Pacific Biopharmaceutical Equipment, by Country USD Million (2016-2021)
  • Table 32. Asia Pacific Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 33. Asia Pacific Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 34. Asia Pacific Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 35. China Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 36. China Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 37. China Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 38. Japan Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 39. Japan Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 40. Japan Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 41. India Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 42. India Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 43. India Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 44. South Korea Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 45. South Korea Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 46. South Korea Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 47. Taiwan Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 48. Taiwan Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 49. Taiwan Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 50. Australia Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 51. Australia Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 52. Australia Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 56. Europe Biopharmaceutical Equipment, by Country USD Million (2016-2021)
  • Table 57. Europe Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 58. Europe Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 59. Europe Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 60. Germany Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 61. Germany Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 62. Germany Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 63. France Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 64. France Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 65. France Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 66. Italy Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 67. Italy Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 68. Italy Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 69. United Kingdom Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 70. United Kingdom Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 71. United Kingdom Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 72. Netherlands Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 73. Netherlands Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 74. Netherlands Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 75. Rest of Europe Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 76. Rest of Europe Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 77. Rest of Europe Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 78. MEA Biopharmaceutical Equipment, by Country USD Million (2016-2021)
  • Table 79. MEA Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 80. MEA Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 81. MEA Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 82. Middle East Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 83. Middle East Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 84. Middle East Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 85. Africa Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 86. Africa Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 87. Africa Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 88. North America Biopharmaceutical Equipment, by Country USD Million (2016-2021)
  • Table 89. North America Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 90. North America Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 91. North America Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 92. United States Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 93. United States Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 94. United States Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 95. Canada Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 96. Canada Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 97. Canada Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 98. Mexico Biopharmaceutical Equipment, by Type USD Million (2016-2021)
  • Table 99. Mexico Biopharmaceutical Equipment, by Application USD Million (2016-2021)
  • Table 100. Mexico Biopharmaceutical Equipment, by End Use USD Million (2016-2021)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Biopharmaceutical Equipment: by Type(USD Million)
  • Table 112. Biopharmaceutical Equipment Filtration Systems , by Region USD Million (2022-2027)
  • Table 113. Biopharmaceutical Equipment Bioreactors , by Region USD Million (2022-2027)
  • Table 114. Biopharmaceutical Equipment Extractors , by Region USD Million (2022-2027)
  • Table 115. Biopharmaceutical Equipment Chromatography , by Region USD Million (2022-2027)
  • Table 116. Biopharmaceutical Equipment Cell Culture , by Region USD Million (2022-2027)
  • Table 117. Biopharmaceutical Equipment Bioprocessing Containers , by Region USD Million (2022-2027)
  • Table 118. Biopharmaceutical Equipment Sterilizers , by Region USD Million (2022-2027)
  • Table 119. Biopharmaceutical Equipment Others , by Region USD Million (2022-2027)
  • Table 120. Biopharmaceutical Equipment: by Application(USD Million)
  • Table 121. Biopharmaceutical Equipment Bioproduction , by Region USD Million (2022-2027)
  • Table 122. Biopharmaceutical Equipment Medical Research , by Region USD Million (2022-2027)
  • Table 123. Biopharmaceutical Equipment: by End Use(USD Million)
  • Table 124. Biopharmaceutical Equipment Pharmaceuticals , by Region USD Million (2022-2027)
  • Table 125. Biopharmaceutical Equipment Supplements , by Region USD Million (2022-2027)
  • Table 126. Biopharmaceutical Equipment Fertilizers , by Region USD Million (2022-2027)
  • Table 127. Biopharmaceutical Equipment Others , by Region USD Million (2022-2027)
  • Table 128. South America Biopharmaceutical Equipment, by Country USD Million (2022-2027)
  • Table 129. South America Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 130. South America Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 131. South America Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 132. Brazil Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 133. Brazil Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 134. Brazil Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 135. Argentina Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 136. Argentina Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 137. Argentina Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 138. Rest of South America Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 139. Rest of South America Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 140. Rest of South America Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 141. Asia Pacific Biopharmaceutical Equipment, by Country USD Million (2022-2027)
  • Table 142. Asia Pacific Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 143. Asia Pacific Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 144. Asia Pacific Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 145. China Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 146. China Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 147. China Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 148. Japan Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 149. Japan Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 150. Japan Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 151. India Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 152. India Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 153. India Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 154. South Korea Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 155. South Korea Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 156. South Korea Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 157. Taiwan Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 158. Taiwan Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 159. Taiwan Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 160. Australia Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 161. Australia Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 162. Australia Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 164. Rest of Asia-Pacific Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 165. Rest of Asia-Pacific Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 166. Europe Biopharmaceutical Equipment, by Country USD Million (2022-2027)
  • Table 167. Europe Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 168. Europe Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 169. Europe Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 170. Germany Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 171. Germany Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 172. Germany Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 173. France Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 174. France Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 175. France Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 176. Italy Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 177. Italy Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 178. Italy Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 179. United Kingdom Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 180. United Kingdom Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 181. United Kingdom Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 182. Netherlands Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 183. Netherlands Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 184. Netherlands Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 185. Rest of Europe Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 186. Rest of Europe Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 187. Rest of Europe Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 188. MEA Biopharmaceutical Equipment, by Country USD Million (2022-2027)
  • Table 189. MEA Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 190. MEA Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 191. MEA Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 192. Middle East Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 193. Middle East Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 194. Middle East Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 195. Africa Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 196. Africa Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 197. Africa Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 198. North America Biopharmaceutical Equipment, by Country USD Million (2022-2027)
  • Table 199. North America Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 200. North America Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 201. North America Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 202. United States Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 203. United States Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 204. United States Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 205. Canada Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 206. Canada Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 207. Canada Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 208. Mexico Biopharmaceutical Equipment, by Type USD Million (2022-2027)
  • Table 209. Mexico Biopharmaceutical Equipment, by Application USD Million (2022-2027)
  • Table 210. Mexico Biopharmaceutical Equipment, by End Use USD Million (2022-2027)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biopharmaceutical Equipment: by Type USD Million (2016-2021)
  • Figure 5. Global Biopharmaceutical Equipment: by Application USD Million (2016-2021)
  • Figure 6. Global Biopharmaceutical Equipment: by End Use USD Million (2016-2021)
  • Figure 7. South America Biopharmaceutical Equipment Share (%), by Country
  • Figure 8. Asia Pacific Biopharmaceutical Equipment Share (%), by Country
  • Figure 9. Europe Biopharmaceutical Equipment Share (%), by Country
  • Figure 10. MEA Biopharmaceutical Equipment Share (%), by Country
  • Figure 11. North America Biopharmaceutical Equipment Share (%), by Country
  • Figure 12. Global Biopharmaceutical Equipment share by Players 2021 (%)
  • Figure 13. Global Biopharmaceutical Equipment share by Players (Top 3) 2021(%)
  • Figure 14. Global Biopharmaceutical Equipment share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 17. 3M Company (United States) Revenue: by Geography 2021
  • Figure 18. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Merck Group (Germany) Revenue: by Geography 2021
  • Figure 20. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 21. GE Healthcare (United States) Revenue: by Geography 2021
  • Figure 22. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Danaher Corporation (United States) Revenue: by Geography 2021
  • Figure 24. Sartorius AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Sartorius AG (Germany) Revenue: by Geography 2021
  • Figure 26. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Eppendorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Eppendorf AG (Germany) Revenue: by Geography 2021
  • Figure 34. Repligen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Repligen Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Global Biopharmaceutical Equipment: by Type USD Million (2022-2027)
  • Figure 37. Global Biopharmaceutical Equipment: by Application USD Million (2022-2027)
  • Figure 38. Global Biopharmaceutical Equipment: by End Use USD Million (2022-2027)
  • Figure 39. South America Biopharmaceutical Equipment Share (%), by Country
  • Figure 40. Asia Pacific Biopharmaceutical Equipment Share (%), by Country
  • Figure 41. Europe Biopharmaceutical Equipment Share (%), by Country
  • Figure 42. MEA Biopharmaceutical Equipment Share (%), by Country
  • Figure 43. North America Biopharmaceutical Equipment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • 3M Company (United States)
  • Merck Group (Germany)
  • GE Healthcare (United States)
  • Danaher Corporation (United States)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Eppendorf AG (Germany)
  • Repligen Corporation (United States)
Additional players considered in the study are as follows:
Philips Healthcare (Netherlands) , Abbott Laboratories (United States) , Roche Holding AG (Switzerland) , Sodexo (France)
Select User Access Type

Key Highlights of Report


May 2022 164 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biopharmaceutical Equipment Market Quantitative research analysis
Global Biopharmaceutical Equipment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Biopharmaceutical Equipment study can be customized to meet your requirements. The market size breakdown by type [Filtration Systems, Bioreactors, Extractors, Chromatography, Cell Culture, Bioprocessing Containers, Sterilizers and Others], by end use application [Bioproduction and Medical Research].
The Biopharmaceutical Equipment Market is gaining popularity and expected to see strong valuation by 2027 .
According to AMA, the Global Biopharmaceutical Equipment market is expected to see growth rate of xx%.

Know More About Global Biopharmaceutical Equipment Market Report?

Have a Query? Click Here

Other Related Reports

Algal Protein Expression System Comprehensive Study by Type (Reagents and Kits, Expression Vectors, Competent Cells, Instruments, Others), Application (Medical Research Institutions, Hospitals, Speci...
$ 3650
Biotinylated Polyclonal Antibodies Comprehensive Study by Type (Primary Antibody, Secondary Antibody), Application (Immunocytochemistry (ICC), Immunoprecipitation (IP), Western Blot (WB), In Situ Hyb...
$ 3500
Kinase Biology Tools and Services Comprehensive Study by Type (Reagents and Kits, Instruments, Accessories and Consumables), Application (Diagnosis, Research), End-User (Academic & Research Institute...
$ 3750
Aquaculture Vaccines Comprehensive Study by Type (Inactivated Vaccines, Live Vaccines), Application (Bacterial Infection, Viral Infection, Fungal Infections, Parasitic Infections), Route of Administr...
$ 3450
Lignans Comprehensive Study by Application (Dietary Supplements, Functional Food, Animal Feed, Cosmetics, Pharmaceuticals, Others), Sales Channel (Direct, Indirect), Source (Seeds, Cereals, Grains, O...
$ 3500
Antibiotic Sensitivity Testing Comprehensive Study by Type (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products, Susceptibility Testing Disks, MIC strips, Susceptib...
$ 3750